Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term extension study of QX005N in adults with chronic rhinosinusitis with nasal polyps
CTR20233391Phase 2Completed
- Sponsor
- Qiansin
- Start
- Nov 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of QX005N in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Qiansin. Started Nov 2023; status: completed.
02
Drugs
QX005N
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20233391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233391.